We are proud that CD&R has been recognized on Inc.'s 2026 Founder-Friendly Investors list, based on feedback from the founders we partner with. Inc. goes directly to entrepreneurs who have sold to or ...

NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...

CD&R (or the “Firm”) today announced that Jim Lico, former President and Chief Executive Officer of Fortive Corporation (NYSE: FTV), a diversified industrial growth company, has been engaged as an ...

American Securities LLC (“American Securities”) and CD&R today announced they completed the sale of Foundation Building Materials, Inc. (“FBM” or the “Company”), a leading building materials and ...

American Securities LLC (“American Securities”) and CD&R today announced they have entered into a definitive agreement to sell Foundation Building Materials, Inc. (“FBM” or the “Company”) to Lowe’s ...

CD&R today announces the sale of a minority stake in Motor Fuel Group (“MFG”) to a group of leading institutional investors including Apollo-managed funds and a number of CD&R’s existing limited ...

CD&R (or the “Firm”) today announced that Albert Manifold, the former chief executive of CRH (NYSE: CRH and LSE: CRH), has become an operating advisor to CD&R funds. In his role, Albert will work ...

Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling ...

A consortium comprising CD&R, Everest UK HoldCo Limited, an entity controlled by the Permira funds, and Olivier Breittmayer, announce today the completion of the acquisition and subsequent delisting ...

À la suite de la finalisation du processus d'information et de consultation des instances représentatives du personnel concernées, Sanofi et CD&R annoncent aujourd’hui avoir signé l’accord d’achat ...

Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale of a 50% controlling stake in ...